Fabrice Rosenstiehl

Active Investor

Interim CEO - ATH at STERIMED Infection Control

Paris, Île-de-France

Fabrice Rosenstiehl, Interim CEO - ATH at STERIMED Infection Control is an active investor based in Paris, Île-de-France. This profile covers what Fabrice Rosenstiehl backs, at which stage, and how founders can reach out in 2026.

Investor type: VCInvestor
Stages: Seed
Invests in: Healthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseConsumer & RetailConsumer Goods (CPG)Climate & Energy
Location: Paris, Île-de-France
Typical check: $250K
Past investments: 3

Notable investments

TesujiEchosensTRI UAE

How to reach Fabrice Rosenstiehl

Angels and operators like Fabrice Rosenstiehl reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Fabrice Rosenstiehl invest in?

Fabrice Rosenstiehl invests in Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Fabrice Rosenstiehl?

Unlock Fabrice Rosenstiehl's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.